Skip to main content
. 2019 Nov 20;12:2405–2410. doi: 10.2147/DMSO.S221969

Table 1.

Characteristics of Patients with and Without Diabetes Complications

Variable No Complications Any Complication P
Number 71 53 ---
Age (years) 32.0 ± 9.6 43.0 ±10.0 <0.001
Male gender (n, (%)) 34 (48) 34 (64) NS
Disease duration (years) 12.2 ± 8.3 18.3 ± 11.0 0.001*
Blood glucose (mg/dL) 165 ± 71 174 ± 75 NS
BMI (kg/m2) 23.5 ± 3.0 26.0 ± 4.4 <0.001
GOT (UI/L) 16 ± 5 20 ± 7 0.003
GPT (UI/L) 15 ± 6 21 ± 11 0.001
Glycated hemoglobin (%) 7.5 ± 1.1 8.0 ± 1.2 NS
Glycated hemoglobin (mmol/mol) 58 ± 8 64 ± 10 NS
HSI 34.0 ± 4.2 37.0 ± 5.5 0.001
HSI > 36 (n, (%)) 23 (32) 26 (49) 0.06
Hypertension (n, (%)) 5 (7) 9 (16) NS
Smokers (n (%)) 13 (18) 10 (18) NS
Total cholesterol (mg/dL) 171 ± 32 175 ± 37 NS
HDL cholesterol (mg/dL) 64 ± 17 59 ± 17 NS
LDL cholesterol (mg/dL) 94 ± 27 99 ± 33 NS
Triglycerides (mg/dL) 63 ± 33 86 ± 40 0.001*
Creatinine (mg/dL) 0.71 ± 0.14 0.78 ± 0.15 0.01
TDI (Unit/day) 36 ± 16 42 ± 19 NS
eGFR CKD-EPI (mL/min) 117 ± 15 104 ± 15 < 0.001
Retinopathy (n, (%)) --- 33 (62) N/A
Carotid Atherosclerosis (n, (%)) --- 19 (35) N/A
Neuropathy (n, (%)) --- 20 (37) N/A
Nephropathy (n, (%)) --- 3 (5) N/A
IHD (n, (%)) --- 0 (0) N/A

Note: *Mann–Whitney test.

Abbreviations: BMI, body mass index; GOT, Glutamat Oxalacetat Transaminase; GPT, Glutamat Pyruvat Transaminase; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HIS, hepatic steatosis index; eGFR, estimated glomerular filtration rate; IHD, ischemic heart disease; TDI, total daily insulin.